Fraunhofer-Carnot cooperation

Thanks to funding by the BMBF and the ANR, a very successful cooperation has evolved between the Carnot-Institut CIRIMAT in Toulouse and the Fraunhofer IGB. It started with the BioCapabili project, in which the partners developed biomimetic bone substitute material with antimicrobial properties.

The desire of the sponsors was not only to promote German-French cooperation, but first and foremost to align research to the current needs and applications of industry. The project was concluded with very good results and received top marks from the experts drawn from science and industry to evaluate it. In order to continue successful, application-oriented collaboration in the future, the CIRIMAT and Fraunhofer IGB scientists launched the BIOCAPABILI Engineering Cluster, a research alliance which has already attracted concrete queries and expressions of interest from various companies.

BioCapabili – biomimetic, antibacterial bone implants for the prevention of local infections


Screening to quantify the antimicrobial properties of the BioCapabili formulations.

Hospital-acquired bone infections, for example, as a result of surgery, are a serious and costly problem, making the prevention of such infection a matter of the highest priority. Calcium phosphate (CaP) apatites are highly suitable candidates for the preparation of biomaterials for bone repair. However, although CaP compounds have been the subject of the extensive industrial research and development, there are still no technological concepts for equipping calcium phosphates with antibacterial properties.

The binational BioCapabili project involves the collaboration between the Fraunhofer IGB and the CIRIMAT Carnot Institute in France, in order to equip bioactive, biomimetic CaP apatite with various antimicrobial compounds and fully investigate them.